undamentalytics Newsletter

Atyr Pharma Inc valuation and forecast

Explore the models for Atyr Pharma Inc, adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Analyst recommendations

9 analysts, Oct 2026
Buy444%
Hold556%
Sell00%

Monthly trend

  1. Oct 20262259
  2. Sep 20262259
  3. Aug 20262259

Counts of recommendations published by analysts covering Atyr Pharma Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

ATYR valuation questions

How does Fundamentalytics value Atyr Pharma Inc?
We use the models that fit Atyr Pharma Inc's business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Atyr Pharma Inc.

Compare with peers